156 related articles for article (PubMed ID: 36549601)
21. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
23. Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.
Miettinen M; Felisiak-Golabek A; Wasag B; Chmara M; Wang Z; Butzow R; Lasota J
Am J Surg Pathol; 2016 Dec; 40(12):1661-1669. PubMed ID: 27454940
[TBL] [Abstract][Full Text] [Related]
24. Digital Quantification of Ki-67 and PHH3 in the Classification of Uterine Smooth Muscle Tumors.
Cao CD; Rico-Castillo J; De Cotiis D; Richard SD; Rosenblum NG; Chan JSY
Int J Gynecol Pathol; 2021 Nov; 40(6):549-555. PubMed ID: 33323861
[TBL] [Abstract][Full Text] [Related]
25. Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.
Zhang Q; Poropatich K; Ubago J; Xie J; Xu X; Frizzell N; Kim J; Kong B; Wei JJ
Int J Gynecol Pathol; 2018 Sep; 37(5):421-430. PubMed ID: 28863073
[TBL] [Abstract][Full Text] [Related]
26. Leiomyoma and Leiomyosarcoma (Primary and Metastatic) of the Oral and Maxillofacial Region: A Clinicopathological and Immunohistochemical Study of 27 Cases.
de Araújo GR; Costa SFDS; Mesquita RA; Gomez RS; Dos Santos JN; Pontes HAR; de Andrade BAB; Romañach MJ; Agostini M; Vargas PA; de Cáceres CVBL; Santos-Silva AR; Ribeiro ACP; Brandão TB; Tomasi RA; Ferreyra RS; de Almeida OP; Fonseca FP
Head Neck Pathol; 2022 Mar; 16(1):294-303. PubMed ID: 34106410
[TBL] [Abstract][Full Text] [Related]
27. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
28. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.
Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
[TBL] [Abstract][Full Text] [Related]
29. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
30. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
[TBL] [Abstract][Full Text] [Related]
33. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.
Mittal KR; Chen F; Wei JJ; Rijhvani K; Kurvathi R; Streck D; Dermody J; Toruner GA
Mod Pathol; 2009 Oct; 22(10):1303-11. PubMed ID: 19633649
[TBL] [Abstract][Full Text] [Related]
34. Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas.
Keyhanian K; Lage JM; Chernetsova E; Sekhon H; Eslami Z; Islam S
Int J Gynecol Pathol; 2020 Jul; 39(4):354-361. PubMed ID: 32515921
[TBL] [Abstract][Full Text] [Related]
35. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization.
Kainsbak J; Hansen ES; Dueholm M
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():130-7. PubMed ID: 26117442
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma.
Dastranj Tabrizi A; Ghojazadeh M; Thagizadeh Anvar H; Vahedi A; Naji S; Mostafidi E; Berenjian S
Adv Pharm Bull; 2015 Dec; 5(Suppl 1):683-7. PubMed ID: 26793616
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.
Rodríguez Y; Báez D; de Oca FM; García C; Dorta I; Reyes R; Valladares F; Almeida TA; Bello AR
Int J Gynecol Pathol; 2011 Jul; 30(4):354-63. PubMed ID: 21623207
[TBL] [Abstract][Full Text] [Related]
38. Immunoexpression of progesterone receptor, epithelial growth factor receptor and galectin-3 in uterine smooth muscle tumors.
Soltan MM; Albasry AM; Eldosouky MK; Abdelhamid HS
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):7-12. PubMed ID: 29729689
[TBL] [Abstract][Full Text] [Related]
39. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
40. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
Sparić R; Andjić M; Babović I; Nejković L; Mitrović M; Štulić J; Pupovac M; Tinelli A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
